 | • レポートコード：TPM-B04120 • 出版社/出版日：Transparency Market Research / 2017年12月 • レポート形態：英文、PDF、184ページ • 納品方法：Eメール • 産業分類：医療機器 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、動脈ステントの世界市場について調べ、動脈ステントの世界規模、市場動向、市場環境、製品別分析、用途別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・動脈ステントの世界市場動向 ・動脈ステントの世界市場環境 ・動脈ステントの世界市場規模 ・動脈ステントの世界市場規模：製品別 ・動脈ステントの世界市場規模：用途別 ・動脈ステントの世界市場：地域別市場規模・分析 ・動脈ステントの北米市場規模・予測 ・動脈ステントのアメリカ市場規模・予測 ・動脈ステントの中南米市場規模・予測 ・動脈ステントのヨーロッパ市場規模・予測 ・動脈ステントのアジア市場規模・予測 ・動脈ステントの日本市場規模・予測 ・動脈ステントの中国市場規模・予測 ・動脈ステントのインド市場規模・予測 ・動脈ステントの中東市場規模・予測 ・動脈ステントのアフリカ市場規模・予測 ・競争状況・関連企業情報 |
Global Arterial Stents Market: Overview
This report on the Global Arterial Stents market analyzes the current and future scenario of the global market. Rise in private and public funding for R&D of novel arterial stents, increase in prevalence of coronary and peripheral arterial disease and their improved diagnosis are boosting the growth of the global arterial stents market. Improved access to the deep long arteries located in the iliac and femoral portion of the body, and availability of well-qualified interventional cardiologists in the developed countries are some of the factors expected to drive the growth of global arterial stents market during the forecast period.
Global Arterial Stents Market: Scope of Study
The arterial stents market report comprises an elaborate executive summary, which includes market snapshot that provides information about various segments. It also provides information and data analysis of the global market with respect to the segments based on product, application, and geography. A detailed qualitative analysis of drivers and restraints, and opportunities has been provided in the market overview section. Additionally, the section comprises exhaustive mapping of all the products & companies operating in the global arterial stents market, to help understand the competitive landscape in the market. Moreover, the global corporate scenario is provided in the report in terms of prominent mergers and acquisitions of arterial stent manufacturers. An overview of critical arterial diseases such as Coronary artery disease (CAD) and Peripheral artery diseases (PAD) in terms of their prevalence, diagnosis, symptoms, and treatment options are provided. This report also provides market attractiveness and its analysis in terms of geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global arterial stents market. The volume forecast and analysis along with the pricing scenario at global level has also been provided in brief for better understanding of the arterial stents market.
Global Arterial Stents Market: Market Segmentation
Based on the product type, the global arterial stents market is segmented into coronary stents and peripheral stents. The coronary stents are further classified into bare metal stents, bioresorbable stents, drug-eluting stents and others. The others segment is comprised of dual therapy stents, covered stents. The peripheral stents segment is further divided into self-expanding stents, balloon-expanding stents, and others (Drug-eluting stents, covered stents etc.). In 2016, coronary stents accounted for a highest market share. Drug-eluting stents sub-segment generated highest revenue in 2016, which is owing to the development and incorporation of anti-restenotic agents for drug-eluting stents, aimed at preventing the incidence of re-stenosis. The peripheral stents segment is anticipated to witness maximum CAGR by 2025, due to the high flexibility of self-expanding peripheral stents and usage of Co–Cr material in their design to impart radial strength. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.
Different types of applications in the arterial stents market are coronary artery, carotid artery, iliac artery, femoral & popliteal artery, and others. The coronary artery segment dominated the market in terms of market share in 2016, and is expected to continue to lead the global market during forecast period. However, femoral & popliteal artery segment is likely to expand with relatively significant CAGR during 2017-2025, due to rising number of PCI procedures on femoral artery, as it is considered to be the most safe and accessible artery for stenting.
Geographically, the global arterial stents has been categorized into five major regions and the key countries in the respective region: North America (U.S. and Canada), Europe (U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC Countries, Israel, and Rest of Middle East & Africa).
Global Arterial Stents Market: Competitive Landscape
The report also profiles major players in the global arterial stents based on various attributes such as company overview, financial overview, product portfolio, business strategies, SWOT analysis, and recent developments. Major players profiled in this report include Abbott Vascular (Abbott Laboratories), Cordis Corporation (A Cardinal Health Company), Boston Scientific Corporation, C. R. Bard, Inc. (BARD Peripheral Vascular), Medtronic, Gore Medical, Cook Medical, Biosensors International Group, Ltd., Lifetech Scientific, and BIOTRONIK AG.
Global Arterial Stents Market has been segmented as given below:
Global Arterial Stents Market, by Product,
Coronary Stents
Bare Metal Stents
Drug-eluting Stents
Bioresorbable Stents
Others
Peripheral Stents
Self-expandable Stents
Balloon-expandable Stents
Others
Global Arterial Stents Market, by Application,
Coronary Artery
Carotid Artery
Iliac Artery
Femoral & Popliteal Artery
Others
Global Arterial Stents Market, by Region
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia Pacific
India
China
Japan
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Israel
Rest of Middle East & Africa
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Arterial Stents Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity
4.4. Global Arterial Stents Market Analysis and Forecasts, 2015–2025
4.5. Market Outlook
4.6. Ker Arterial Diseases: Epidemiology
4.6.1. Coronary Artery Diseases (CAD)
4.6.2. Peripheral Artery Diseases (PAD)
4.7. Arterial Stents: Product Mapping
4.8. Arterial Stents Market: Key Mergers and Acquisitions
4.9. Arterial Stents: Global Volume Forecast and Analysis
5. Global Arterial Stents Market Analysis and Forecasts, By Product
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Market Value Forecast By Product, 2015–2025
5.3.1. Coronary Stents
5.3.1.1. Bare Metal Stents
5.3.1.2. Drug-eluting Stents
5.3.1.3. Bioresorbable Stents
5.3.1.4. Others
5.3.2. Peripheral Stents
5.3.2.1. Self-expanding Stents
5.3.2.2. Balloon-expanding Stents
5.3.2.3. Others
5.4. Market Attractiveness By Product
5.5. Key Trends
6. Global Arterial Stents Market Analysis and Forecasts, By Application
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Application, 2015–2025
6.3.1. Coronary Artery
6.3.2. Carotid Artery
6.3.3. Iliac Artery
6.3.4. Femoral & Popliteal Artery
6.3.5. Others
6.4. Market Attractiveness By Application
6.5. Key Trends
7. Global Arterial Stents Market Analysis and Forecasts, By Region
7.1. Key Findings
7.2. Market Value Forecast By Region
7.2.1. North America
7.2.2. Europe
7.2.3. Asia Pacific
7.2.4. Latin America
7.2.5. Middle East & Africa
7.3. Market Attractiveness By Country/Region
8. North America Arterial Stents Market Analysis and Forecast
8.1. Introduction
8.1.1. Key Findings
8.2. Market Value Forecast By Product, 2015–2025
8.2.1. Coronary Stents
8.2.1.1. Bare Metal Stents
8.2.1.2. Drug-eluting Stents
8.2.1.3. Bioresorbable Stents
8.2.1.4. Others
8.2.2. Peripheral Stents
8.2.2.1. Self-expanding Stents
8.2.2.2. Balloon-expanding Stents
8.2.2.3. Others
8.3. Market Value Forecast By Application, 2015–2025
8.3.1. Coronary Artery
8.3.2. Carotid Artery
8.3.3. Iliac Artery
8.3.4. Femoral & Popliteal Artery
8.3.5. Others
8.4. Market Value Forecast By Country, 2015–2025
8.4.1. U.S.
8.4.2. Canada
8.5. Market Attractiveness Analysis
8.5.1. By Product
8.5.2. By Application
8.5.3. By Country
8.6. Key trends
9. Europe Arterial Stents Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast By Product, 2015–2025
9.2.1. Coronary Stents
9.2.1.1. Bare Metal Stents
9.2.1.2. Drug-eluting Stents
9.2.1.3. Bioresorbable Stents
9.2.1.4. Others
9.2.2. Peripheral Stents
9.2.2.1. Self-expanding Stents
9.2.2.2. Balloon-expanding Stents
9.2.2.3. Others
9.3. Market Value Forecast By Application, 2015–2025
9.3.1. Coronary Artery
9.3.2. Carotid Artery
9.3.3. Iliac Artery
9.3.4. Femoral & Popliteal Artery
9.3.5. Others
9.4. Market Value Forecast By Country, 2015–2025
9.4.1. Germany
9.4.2. U.K.
9.4.3. France
9.4.4. Spain
9.4.5. Italy
9.4.6. Rest of Europe
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By Application
9.5.3. By Country
9.6. Key Trends
10. Asia Pacific Arterial Stents Market Analysis and Forecast
10.1.Introduction
10.1.1. Key Findings
10.2.Market Value Forecast By Product, 2015–2025
10.2.1. Coronary Stents
10.2.1.1. Bare Metal Stents
10.2.1.2. Drug-eluting Stents
10.2.1.3. Bioresorbable Stents
10.2.1.4. Others
10.2.2. Peripheral Stents
10.2.2.1. Self-expanding Stents
10.2.2.2. Balloon-expanding Stents
10.2.2.3. Others
10.3.Market Value Forecast By Application, 2015–2025
10.3.1. Coronary Artery
10.3.2. Carotid Artery
10.3.3. Iliac Artery
10.3.4. Femoral & Popliteal Artery
10.3.5. Others
10.4.Market Value Forecast By Country, 2015–2025
10.4.1. China
10.4.2. India
10.4.3. Japan
10.4.4. Rest of Asia Pacific
10.5.Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By Application
10.5.3. By Country
10.6. Key Trends
11. Latin America Arterial Stents Market Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2.Market Value Forecast By Product, 2015–2025
11.2.1. Coronary Stents
11.2.1.1. Bare Metal Stents
11.2.1.2. Drug-eluting Stents
11.2.1.3. Bioresorbable Stents
11.2.1.4. Others
11.2.2. Peripheral Stents
11.2.2.1. Self-expanding Stents
11.2.2.2. Balloon-expanding Stents
11.2.2.3. Others
11.3.Market Value Forecast By Application, 2015–2025
11.3.1. Coronary Artery
11.3.2. Carotid Artery
11.3.3. Iliac Artery
11.3.4. Femoral & Popliteal Artery
11.3.5. Others
11.4.Market Value Forecast By Country, 2015–2025
11.4.1. Brazil
11.4.2. Mexico
11.4.3. Rest of Latin America
11.5.Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By Application
11.5.3. By Country
11.6. Key Trends
12. Middle East & Africa Arterial Stents Market Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2.Market Value Forecast By Product, 2015–2025
12.2.1. Coronary Stents
12.2.1.1. Bare Metal Stents
12.2.1.2. Drug-eluting Stents
12.2.1.3. Bioresorbable Stents
12.2.1.4. Others
12.2.2. Peripheral Stents
12.2.2.1. Self-expanding Stents
12.2.2.2. Balloon-expanding Stents
12.2.2.3. Others
12.3.Market Value Forecast By Application, 2015–2025
12.3.1. Coronary Artery
12.3.2. Carotid Artery
12.3.3. Iliac Artery
12.3.4. Femoral & Popliteal Artery
12.3.5. Others
12.4.Market Value Forecast By Country, 2015–2025
12.4.1. GCC Countries
12.4.2. South Africa
12.4.3. Israel
12.4.4. Rest of Middle East & Africa
12.5.Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By Application
12.5.3. By Country
12.6. Key Trends
13. Competition Landscape
13.1.Market Player – Competition Matrix (By Tier and Size of companies)
13.2.Market Share Analysis By Company (2016)
13.3.Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
13.3.1. Abbott Vascular (Abbott Laboratories)
13.3.1.1. Overview
13.3.1.2.Financials
13.3.1.3.Recent Developments
13.3.1.4.SWOT Analysis
13.3.1.5.Strategic Overview
13.3.2. Cordis Corporation (A Cardinal Health Company)
13.3.2.1. Overview
13.3.2.2.Financials
13.3.2.3.Recent Developments
13.3.2.4.SWOT Analysis
13.3.2.5.Strategic Overview
13.3.3. Boston Scientific Corporation
13.3.3.1. Overview
13.3.3.2.Financials
13.3.3.3.Recent Developments
13.3.3.4.SWOT Analysis
13.3.3.5.Strategic Overview
13.3.4. Medtronic
13.3.4.1. Overview
13.3.4.2.Financials
13.3.4.3.Recent Developments
13.3.4.4.SWOT Analysis
13.3.4.5.Strategic Overview
13.3.5. C. R. Bard, Inc. (BARD Peripheral Vascular)
13.3.5.1. Overview
13.3.5.2.Financials
13.3.5.3.Recent Developments
13.3.5.4.SWOT Analysis
13.3.5.5.Strategic Overview
13.3.6. Biosensors International Group, Ltd.
13.3.6.1. Overview
13.3.6.2.Financials
13.3.6.3.Recent Developments
13.3.6.4.SWOT Analysis
13.3.6.5.Strategic Overview
13.3.7. Lifetech Scientific
13.3.7.1. Overview
13.3.7.2.Financials
13.3.7.3.Recent Developments
13.3.7.4.SWOT Analysis
13.3.7.5.Strategic Overview
13.3.8. BIOTRONIK AG
13.3.8.1. Overview
13.3.8.2.Financials
13.3.8.3.Recent Developments
13.3.8.4.SWOT Analysis
13.3.8.5.Strategic Overview
13.3.9. Cook Medical
13.3.9.1. Overview
13.3.9.2.Financials
13.3.9.3.Recent Developments
13.3.9.4.SWOT Analysis
13.3.9.5.Strategic Overview
13.3.10. W. L. Gore & Associates, Inc.
13.3.10.1. Overview
13.3.10.2.Financials
13.3.10.3.Recent Developments
13.3.10.4.SWOT Analysis
13.3.10.5.Strategic Overview
Table 01 Product Mapping (Abbott Vascular)
Table 02 Product Mapping (Boston Scientific Corporation)
Table 03 Product Mapping (Biotronik AG, Meril Lifesciences, JOTEC GmbH)
Table 04 Product Mapping (Biosensors International, ENDOLOGIX, INC)
Table 05 Product Mapping (Cordis Corporation, Terumo Corporation)
Table 06 Product Mapping (Medtronic)
Table 07 Product Mapping (B. Braun Melsungen AG, Microport)
Table 08 Product Mapping (Vascular Concept)
Table 09 Product Mapping (Translumina GmBH, Lombard Medical, Scitech, Minvasys)
Table 10 Product Mapping (iVascular SLU, Elixir Medical Corporation, Andramed GmbH)
Table 11 Product Mapping (Endocor GmBH, Arthesys)
Table 12 Product Mapping (Eurocor GmbH, ORBUSNEICH, Hexacath)
Table 13 Product Mapping (Amaranth Medical, InSitu Technologies, Inc., Kyoto Medical)
Table 14 Product Mapping (Comed B. V., Alvimedica, Accura Medizintechnik GmbH, Micelle Technologies)
Table 15 Product Mapping (ELLA - CS, Cook Medical, Lepu Medical)
Table 16 Arterial Stents Average Selling Prices (US$), and Analysis, By Stent Type, 2016
Table 17 Global Arterial Stents Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 18 Global Stents Market Size (US$ Mn) Forecast, by Arterial Stents – Coronary Stents, 2015–2025
Table 19 Global Stents Market Size (US$ Mn) Forecast, by Arterial Stents – Peripheral Stents, 2015–2025
Table 20 Global Arterial Stents Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 21 Global Arterial Stents Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 22 North America Arterial Stents Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 23 North America Arterial Stents Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 24 North America Stents Market Size (US$ Mn) Forecast, by Arterial Stents – Coronary Stents, 2015–2025
Table 25 North America Stents Market Size (US$ Mn) Forecast, by Arterial Stents – Peripheral Stents, 2015–2025
Table 26 North America Arterial Stents Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 27 Europe Arterial Stents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 28 Europe Arterial Stents Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 29 Europe Stents Market Size (US$ Mn) Forecast, by Arterial Stents – Coronary Stents, 2015–2025
Table 30 Europe Stents Market Size (US$ Mn) Forecast, by Arterial Stents – Peripheral Stents, 2015–2025
Table 31 Europe Arterial Stents Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 32 Asia Pacific Arterial Stents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 33 Asia Pacific Arterial Stents Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 34 Asia Pacific Stents Market Size (US$ Mn) Forecast, by Arterial Stents – Coronary Stents, 2015–2025
Table 35 Asia Pacific Stents Market Size (US$ Mn) Forecast, by Arterial Stents – Peripheral Stents, 2015–2025
Table 36 Asia Pacific Arterial Stents Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 37 Latin America Arterial Stents Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 38 Latin America Arterial Stents Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 39 Latin America Stents Market Size (US$ Mn) Forecast, by Arterial Stents – Coronary Stents, 2015–2025
Table 40 Latin America Stents Market Size (US$ Mn) Forecast, by Arterial Stents – Peripheral Stents, 2015–2025
Table 41 Latin America Arterial Stents Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 42 Middle East & Africa Arterial Stents Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 43 Middle East & Africa Arterial Stents Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 44 Middle East & Africa Stents Market Size (US$ Mn) Forecast, by Arterial Stents – Coronary Stents, 2015–2025
Table 45 Middle East & Africa Stents Market Size (US$ Mn) Forecast, by Arterial Stents – Peripheral Stents, 2015–2025
Table 46 Middle East & Africa Arterial Stents Market Size (US$ Mn) Forecast, by Application, 2015–2025